Most Profitable Pharmaceuticals Companies

Net Income
Net IncomeEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
107.93 B
 0.23 
 1.04 
 0.24 
2NVO Novo Nordisk AS
100.99 B
 0.01 
 2.54 
 0.02 
3RDY Dr Reddys Laboratories
57.24 B
(0.05)
 1.44 
(0.07)
4MRK Merck Company
17.13 B
 0.25 
 1.64 
 0.41 
5JNJ Johnson Johnson
14.07 B
 0.16 
 0.99 
 0.15 
6NVS Novartis AG ADR
11.94 B
 0.12 
 1.26 
 0.15 
7LLY Eli Lilly and
10.59 B
 0.28 
 1.76 
 0.49 
8AZN AstraZeneca PLC ADR
8.69 B
 0.16 
 1.25 
 0.20 
9PFE Pfizer Inc
8.05 B
 0.05 
 1.34 
 0.07 
10SNY Sanofi ADR
5.5 B
 0.01 
 1.26 
 0.02 
11GSK GlaxoSmithKline PLC ADR
2.95 B
 0.18 
 1.48 
 0.27 
12ZTS Zoetis Inc
2.5 B
(0.07)
 2.28 
(0.16)
13RPRX Royalty Pharma Plc
1.33 B
 0.15 
 1.63 
 0.25 
14OGN Organon Co
864 M
(0.04)
 4.31 
(0.16)
15JAZZ Jazz Pharmaceuticals PLC
560.12 M
 0.13 
 3.15 
 0.41 
16ELAN Elanco Animal Health
338 M
 0.12 
 2.14 
 0.26 
17PBH Prestige Brand Holdings
214.6 M
 0.04 
 1.20 
 0.05 
18AMPH Amphastar P
159.52 M
 0.11 
 2.35 
 0.27 
19HRMY Harmony Biosciences Holdings
145.49 M
 0.25 
 2.39 
 0.60 
20CORT Corcept Therapeutics Incorporated
141.21 M
(0.11)
 7.33 
(0.81)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.